Some of Our Cells Are Defying Death. Scientists Just Discovered How.

Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...
Frontiers

Bcl-2 Proteins: Pioneering Targets in Cancer Immunotherapy

The Bcl-2 family of proteins, known for their crucial role in regulating apoptosis, present an intriguing opportunity for advancing cancer immunotherapy. Recent studies have highlighted their ...

Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced that the China National Intellectual Property ...
Investing.com India

Hoth Therapeutics stock rises after securing Chinese patent for cancer therapy

The China National Intellectual Property Administration approved the patent covering Hoth’s HT-KIT technology, which is designed to induce apoptosis (programmed cell death) in cancer cells by ...
Frontiers

Cuproptosis in Cancer: Mechanisms, Microenvironment, and Therapeutic Exploitation

The field of regulated cell death has undergone a transformative shift with the discovery of novel modalities beyond apoptosis, such as ferroptosis, which ...